ORKA
Oruka Therapeutics, Inc.
Company overview
- Market capitalization
- $5.57B
- Employees
- 68
- Latest publication
- 2026-09-29
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -50,107,000USD | -36,434,000USD | -34,431,000USD | -34,105,000USD | -28,429,000USD | -25,086,000USD | -38,329,174USD | -29,449,000USD |
| Net Income | -41,206,000USD | -31,820,000USD | -29,583,000USD | -30,277,000USD | -24,574,000USD | -20,999,000USD | -33,392,265USD | -28,623,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | — | 0USD |
| Cost Of Revenue | — | 43,000USD | 28,000USD | — | 19,000USD | 16,000USD | 16,000USD | -20,000USD |
| Gross Profit | — | -43,000USD | -28,000USD | — | -19,000USD | -16,000USD | -16,000USD | 20,000USD |
| Research Development | — | 29,145,000USD | 27,640,000USD | 28,988,000USD | 24,087,000USD | 19,925,000USD | 32,326,630USD | 25,691,000USD |
| Selling General Administrative | — | 7,289,000USD | 6,791,000USD | 5,117,000USD | 4,342,000USD | 5,161,000USD | 5,675,272USD | 3,758,000USD |
| Total Operating Expenses | — | 36,391,000USD | 34,403,000USD | 34,105,000USD | 28,429,000USD | 25,086,000USD | 38,329,174USD | 29,449,000USD |
| Interest Income | — | 4,606,000USD | 4,849,000USD | 3,832,000USD | 3,857,000USD | 4,092,000USD | — | 1,330,000USD |
| Net Interest Income | — | 4,606,000USD | 4,849,000USD | 3,832,000USD | 3,857,000USD | 4,092,000USD | — | 826,000USD |
| Income Before Tax | — | -31,820,000USD | -29,583,000USD | -30,277,000USD | -24,574,000USD | -20,999,000USD | -33,392,265USD | -28,623,000USD |
| Net Income From Continuing Ops | — | -31,820,000USD | -29,583,000USD | -30,277,000USD | -24,574,000USD | -20,999,000USD | — | -28,623,000USD |
| Ebit | — | -36,434,000USD | -34,431,000USD | -30,277,000USD | -24,574,000USD | -20,999,000USD | -37,456,447USD | -28,099,000USD |
| Ebitda | — | -36,391,000USD | -34,403,000USD | -30,257,000USD | -24,555,000USD | -20,983,000USD | -37,437,992USD | -28,119,000USD |
| Depreciation And Amortization | — | 43,000USD | 28,000USD | 20,000USD | 19,000USD | 16,000USD | 18,455USD | -20,000USD |
| Reconciled Depreciation | — | 43,000USD | 28,000USD | 20,000USD | 19,000USD | 16,000USD | — | — |
| Total Other Income Expense Net | — | 4,614,000USD | 4,848,000USD | 3,828,000USD | 3,855,000USD | 4,087,000USD | 4,936,909USD | 826,000USD |
| Interest Expense | — | — | 0USD | 0USD | 0USD | 0USD | — | 504,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 327,272USD | — |
| Source | 0001213900-26-087231Verified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | — | — | — | — | — | — | — |
| Cost Of Revenue | 83,000USD | 27,000USD | 111,000USD | 114,000USD | 91,000USD | 93,000USD | 89,000USD | 22,000USD |
| Gross Profit | -83,000USD | -27,000USD | -111,000USD | -114,000USD | -91,000USD | -93,000USD | -89,000USD | -22,000USD |
| Research Development | 100,640,000USD | 75,060,000USD | 1,013,000USD | 4,464,000USD | 13,832,000USD | 4,992,000USD | 1,833,000USD | 4,239,000USD |
| Selling General Administrative | 21,411,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 121,968,000USD | 88,096,000USD | 7,185,000USD | 9,727,000USD | 19,244,000USD | 9,673,000USD | 5,725,000USD | 8,096,000USD |
| Operating Income | -122,051,000USD | -88,123,000USD | -7,296,000USD | -9,841,000USD | -19,335,000USD | -9,766,000USD | -5,814,000USD | -8,118,000USD |
| Interest Income | 16,630,000USD | — | — | — | — | — | — | — |
| Interest Expense | 0USD | 1,468,000USD | — | — | — | 9,000USD | 7,000USD | — |
| Net Interest Income | 16,630,000USD | — | — | — | — | — | — | — |
| Income Before Tax | -105,433,000USD | -83,724,000USD | -5,339,000USD | -9,926,000USD | -19,322,000USD | -9,747,000USD | -5,649,000USD | -7,964,000USD |
| Net Income | -105,433,000USD | -83,724,000USD | -5,339,000USD | -9,926,000USD | -19,322,000USD | -9,738,000USD | -5,482,000USD | -7,933,000USD |
| Net Income From Continuing Ops | -105,433,000USD | — | — | — | — | — | — | — |
| Ebit | -122,051,000USD | -82,256,000USD | -5,339,000USD | -9,926,000USD | -19,322,000USD | -9,738,000USD | -5,642,000USD | -7,964,000USD |
| Ebitda | -121,968,000USD | -82,229,000USD | -5,228,000USD | -9,812,000USD | -19,231,000USD | -9,645,000USD | -5,553,000USD | -7,942,000USD |
| Depreciation And Amortization | 83,000USD | 27,000USD | 111,000USD | 114,000USD | 91,000USD | 93,000USD | 89,000USD | 22,000USD |
| Reconciled Depreciation | 83,000USD | — | — | — | — | — | — | — |
| Total Other Income Expense Net | 16,618,000USD | 4,399,000USD | 1,957,000USD | -85,000USD | 13,000USD | 19,000USD | 165,000USD | 154,000USD |
| Unclassified Operating Expenses | — | 13,036,000USD | 6,172,000USD | 5,263,000USD | 5,412,000USD | 4,681,000USD | 3,892,000USD | 3,857,000USD |
| Income Tax Expense | — | — | — | — | — | -9,000USD | -167,000USD | -31,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,139,394,000USD | 504,480,000USD | 488,617,000USD | 509,251,000USD | 357,418,000USD | 377,112,000USD | 396,019,000USD | 414,090,000USD |
| Cash And Equivalents | 268,470,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 873,564,000USD | 388,829,000USD | 337,044,000USD | 349,155,000USD | 328,406,000USD | 349,094,000USD | 375,648,000USD | 410,875,000USD |
| Short Term Investments | 605,094,000USD | 339,309,000USD | 290,109,000USD | 257,902,000USD | 263,010,000USD | 265,522,000USD | 314,073,000USD | — |
| Long Term Investments | 252,017,000USD | 107,123,000USD | 142,539,000USD | 151,763,000USD | 23,053,000USD | 23,953,000USD | 18,069,000USD | — |
| Total Current Assets | 884,559,000USD | 395,249,000USD | 343,857,000USD | 355,163,000USD | 332,012,000USD | 352,083,000USD | 376,869,000USD | 412,949,000USD |
| Other Current Assets | 10,995,000USD | 6,420,000USD | 6,813,000USD | 6,008,000USD | 3,606,000USD | 2,989,000USD | 1,221,000USD | 2,074,000USD |
| Other Non Current Assets | 128,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 24,845,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 22,968,000USD | 16,633,000USD | 15,374,000USD | 20,967,000USD | 12,110,000USD | 11,723,000USD | 13,043,000USD | 18,039,000USD |
| Total Stockholder Equity | 1,114,549,000USD | 486,720,000USD | 471,930,000USD | 486,791,000USD | 343,642,000USD | 364,725,000USD | 382,221,000USD | 342,368,000USD |
| Total Equity Including Noncontrolling Interest | 1,114,549,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,690,000USD | 2,005,000USD | 2,118,000USD | 2,222,000USD | 2,250,000USD | 973,000USD | 1,038,000USD | 1,098,000USD |
| Accounts Payable | 7,950,000USD | 3,662,000USD | 4,155,000USD | 2,208,000USD | 4,664,000USD | 3,545,000USD | 3,462,000USD | 8,502,000USD |
| Short Term Debt | 669,000USD | 680,000USD | 619,000USD | 419,000USD | 660,000USD | 283,000USD | 213,000USD | 146,000USD |
| Common Stock | 61,000USD | 50,000USD | 49,000USD | 48,000USD | 37,000USD | 37,000USD | 37,000USD | 35,000USD |
| Retained Earnings | -262,183,000USD | -220,977,000USD | -189,157,000USD | -159,574,000USD | -129,297,000USD | -104,723,000USD | -83,724,000USD | -57,943,000USD |
| Accumulated Other Comprehensive Income | -1,703,000USD | -480,000USD | 546,000USD | 185,000USD | -27,000USD | -6,000USD | -41,000USD | — |
| Total Liab | — | 17,760,000USD | 16,687,000USD | 22,460,000USD | 13,776,000USD | 12,387,000USD | 13,798,000USD | 71,722,000USD |
| Other Current Liab | — | 12,291,000USD | 10,600,000USD | 18,340,000USD | 6,786,000USD | 7,895,000USD | 9,368,000USD | 9,401,000USD |
| Capital Stock | — | 50,000USD | 49,000USD | 2,979,000USD | 2,968,000USD | 2,968,000USD | 2,968,000USD | 2,966,000USD |
| Cash | — | 49,520,000USD | 46,935,000USD | 91,253,000USD | 65,396,000USD | 83,572,000USD | 61,575,000USD | 410,875,000USD |
| Net Debt | — | -47,713,000USD | -45,003,000USD | -89,341,000USD | -63,070,000USD | -82,625,000USD | -60,607,000USD | -409,887,000USD |
| Short Long Term Debt Total | — | 1,807,000USD | 1,932,000USD | 1,912,000USD | 2,326,000USD | 947,000USD | 968,000USD | 988,000USD |
| Property Plant Equipment Gross | — | 2,005,000USD | 2,118,000USD | 2,222,000USD | 2,250,000USD | 973,000USD | 1,038,000USD | 1,098,000USD |
| Common Stock Shares Outstanding | — | 55,172,410shares | 54,420,045shares | 44,067,059shares | 42,233,089shares | 41,679,560shares | 16,789,362shares | 15,013,655shares |
| Non Current Assets Total | — | 109,231,000USD | 144,760,000USD | 154,088,000USD | 25,406,000USD | 25,028,999USD | 19,150,000USD | 1,141,000USD |
| Non Current Liabilities Total | — | 1,127,000USD | 1,313,000USD | 1,493,000USD | 1,666,000USD | 663,999USD | 755,000USD | 53,683,000USD |
| Non Currrent Assets Other | — | 103,000USD | 103,000USD | 103,000USD | 103,000USD | 102,999USD | 43,000USD | 43,000USD |
| Net Working Capital | — | 378,616,000USD | 328,483,000USD | 334,196,000USD | 319,902,000USD | 340,360,000USD | 363,826,000USD | 394,910,000USD |
| Unclassified Non Current Liabilities | — | 1,127,000USD | 1,313,000USD | 1,493,000USD | 1,666,000USD | — | — | 53,683,000USD |
| Unclassified Equity | — | 708,077,000USD | 660,443,000USD | 643,153,000USD | 469,961,000USD | 466,449,000USD | 462,981,000USD | 397,310,000USD |
| Source | 0001213900-26-087231DeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 488,617,000USD | 396,019,000USD | 37,861,000USD | 43,085,000USD | 54,924,000USD | 50,429,000USD | 8,536,000USD | 6,825,000USD |
| Other Current Assets | 6,813,000USD | 1,221,000USD | 161,000USD | 254,000USD | 1,062,000USD | 897,000USD | 117,000USD | 169,000USD |
| Total Liab | 16,687,000USD | 13,798,000USD | 841,000USD | 1,412,000USD | 3,881,000USD | 3,908,000USD | 926,000USD | 793,000USD |
| Total Stockholder Equity | 471,930,000USD | 382,221,000USD | 37,020,000USD | 41,673,000USD | 51,043,000USD | 46,521,000USD | 7,610,000USD | 6,032,000USD |
| Other Current Liab | 10,600,000USD | 9,368,000USD | 561,000USD | 695,000USD | 2,281,000USD | 1,685,000USD | 483,000USD | 563,000USD |
| Common Stock | 49,000USD | 37,000USD | 14,000USD | 14,000USD | 14,000USD | 10,000USD | 2,000USD | 14,000USD |
| Capital Stock | 49,000USD | 2,968,000USD | — | — | — | — | — | — |
| Retained Earnings | -189,157,000USD | -83,724,000USD | -188,741,000USD | -183,402,000USD | -173,476,000USD | -154,154,000USD | -144,416,000USD | -138,934,000USD |
| Cash | 46,935,000USD | 61,575,000USD | 37,431,000USD | 42,445,000USD | 53,359,000USD | 49,071,000USD | 8,363,000USD | 6,608,000USD |
| Cash And Short Term Investments | 337,044,000USD | 375,648,000USD | 37,431,000USD | 42,445,000USD | 53,359,000USD | 49,071,000USD | 8,363,000USD | 6,608,000USD |
| Total Current Assets | 343,857,000USD | 376,869,000USD | 37,592,000USD | 42,699,000USD | 54,421,000USD | 49,968,000USD | 8,480,000USD | 6,777,000USD |
| Total Current Liabilities | 15,374,000USD | 13,043,000USD | 637,000USD | 1,132,000USD | 3,498,000USD | 3,499,000USD | 926,000USD | 793,000USD |
| Net Debt | -45,003,000USD | -60,607,000USD | -37,151,000USD | -42,062,000USD | -52,876,000USD | -48,621,000USD | -8,338,000USD | -6,608,000USD |
| Short Term Debt | 619,000USD | 213,000USD | 76,000USD | 103,000USD | 100,000USD | 41,000USD | 25,000USD | — |
| Short Long Term Debt Total | 1,932,000USD | 968,000USD | 280,000USD | 383,000USD | 483,000USD | 450,000USD | 25,000USD | — |
| Long Term Investments | 142,539,000USD | 18,069,000USD | — | — | — | — | — | — |
| Short Term Investments | 290,109,000USD | 314,073,000USD | — | — | — | — | — | — |
| Accounts Payable | 4,155,000USD | 3,462,000USD | — | 334,000USD | 1,117,000USD | 1,773,000USD | 418,000USD | 230,000USD |
| Property Plant Equipment Net | 2,118,000USD | 1,038,000USD | 257,000USD | 368,000USD | 485,000USD | 449,000USD | 32,000USD | 24,000USD |
| Property Plant Equipment Gross | 2,118,000USD | 1,038,000USD | — | — | — | — | — | — |
| Accumulated Other Comprehensive Income | 546,000USD | -41,000USD | — | — | — | — | — | — |
| Common Stock Shares Outstanding | 45,614,142shares | 16,789,362shares | 14,415,877shares | 14,410,143shares | 13,903,871shares | 4,710,237shares | 110,102shares | 64,115shares |
| Non Current Assets Total | 144,760,000USD | 19,150,000USD | 269,000USD | 386,000USD | 503,000USD | 461,000USD | 55,999USD | 48,000USD |
| Non Current Liabilities Total | 1,313,000USD | 755,000USD | 204,000USD | 280,000USD | 383,000USD | 409,000USD | — | — |
| Non Currrent Assets Other | 103,000USD | 43,000USD | 12,000USD | 18,000USD | 18,000USD | 12,000USD | 23,999USD | 24,000USD |
| Net Working Capital | 328,483,000USD | 363,826,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 1,313,000USD | — | — | — | — | — | — | — |
| Unclassified Equity | 660,443,000USD | 462,981,000USD | 225,747,000USD | 225,061,000USD | 224,505,000USD | 200,665,000USD | 152,024,000USD | 144,952,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 86,000USD |
| Stock Based Compensation | 14,252,000USD |
| Change To Liabilities | 3,758,000USD |
| Change In Working Capital | -4,207,000USD |
| Operating Cash Flow | -56,723,000USD |
| Capital Expenditures | -73,000USD |
| Net Investments | -425,311,000USD |
| Investing Cash Flow | -425,384,000USD |
| Common Stock Issuance | 337,000USD |
| Unclassified Financing Cash Flow | 703,305,000USD |
| Financing Cash Flow | 703,642,000USD |
| Change In Cash | 221,535,000USD |
| End Cash Flow | 268,470,000USD |
| Source | 0001213900-26-087231DeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -31,820,000USD | -29,583,000USD | -30,277,000USD | -24,574,000USD | -20,999,000USD | -25,781,000USD | -28,623,000USD | -2,678,000USD |
| Depreciation | 43,000USD | 28,000USD | 20,000USD | 19,000USD | 16,000USD | 16,000USD | — | 12,000USD |
| Stock Based Compensation | 6,968,000USD | 4,115,000USD | 10,165,000USD | 5,077,000USD | 4,883,000USD | — | — | 683,000USD |
| Other Non Cash Items | 6,665,000USD | 3,591,000USD | 6,690,000USD | -1,378,000USD | -1,735,000USD | 2,967,000USD | -13,577,000USD | 112,000USD |
| Change In Working Capital | 1,534,000USD | 3,370,000USD | 1,965,000USD | -2,289,000USD | -3,034,000USD | 3,980,000USD | 7,343,000USD | -80,000USD |
| Total Cash From Operating Activities | -23,578,000USD | -22,594,000USD | -21,602,000USD | -23,145,000USD | -20,869,000USD | -18,818,000USD | -34,857,000USD | -2,634,000USD |
| Capital Expenditures | -73,000USD | -63,000USD | -99,000USD | -34,000USD | -13,000USD | -18,000USD | -171,000USD | 0USD |
| Free Cash Flow | -23,651,000USD | -22,657,000USD | -21,701,000USD | -23,179,000USD | -20,882,000USD | -18,836,000USD | -35,028,000USD | -2,634,000USD |
| Investments | -14,364,000USD | -21,959,000USD | -122,449,000USD | 4,860,000USD | 42,866,000USD | — | — | 0USD |
| Total Cashflows From Investing Activities | -14,437,000USD | -22,022,000USD | -122,449,000USD | 4,860,000USD | 42,866,000USD | -329,956,000USD | -171,000USD | — |
| Total Cash From Financing Activities | 40,600,000USD | 298,000USD | 169,908,000USD | 109,000USD | 0USD | -526,000USD | 450,051,000USD | 14,000USD |
| Issuance Of Capital Stock | 40,600,000USD | 562,000USD | 0USD | 109,000USD | 0USD | — | — | 0USD |
| Change In Cash | 2,585,000USD | -44,318,000USD | 25,857,000USD | -18,176,000USD | 21,997,000USD | -349,300,000USD | 377,592,000USD | -2,620,000USD |
| Begin Period Cash Flow | 46,935,000USD | 91,253,000USD | 65,396,000USD | 83,572,000USD | 61,575,000USD | 410,875,000USD | 33,283,000USD | 35,903,000USD |
| End Period Cash Flow | 49,520,000USD | 46,935,000USD | 91,253,000USD | 65,396,000USD | 83,572,000USD | 61,575,000USD | 410,875,000USD | 33,283,000USD |
| Unclassified Operating Cash Flow | -6,968,000USD | -4,115,000USD | -10,165,000USD | — | — | — | — | — |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | — | — | 0USD |
| Other Cashflows From Investing Activities | — | — | -122,350,000USD | — | — | -329,938,000USD | — | — |
| Other Cashflows From Financing Activities | — | — | 169,908,000USD | — | — | -29,920,000USD | 29,920,000USD | — |
| Unclassified Investing Cash Flow | — | — | 122,449,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | 29,394,000USD | 420,131,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -105,433,000USD | -83,724,000USD | -9,926,000USD | -19,322,000USD | -9,738,000USD | -5,482,000USD | -7,933,000USD | -18,490,000USD |
| Depreciation | 83,000USD | 27,000USD | 114,000USD | 91,000USD | 93,000USD | 89,000USD | 22,000USD | 27,000USD |
| Stock Based Compensation | 24,240,000USD | — | — | — | — | — | — | — |
| Other Non Cash Items | 19,695,000USD | 14,269,000USD | 561,000USD | 497,000USD | 43,000USD | 151,000USD | 275,000USD | 906,000USD |
| Change In Working Capital | -2,555,000USD | 11,591,000USD | -1,661,000USD | -28,000USD | 1,877,000USD | 441,000USD | -608,000USD | 85,000USD |
| Total Cash From Operating Activities | -88,210,000USD | -57,837,000USD | -10,912,000USD | -18,762,000USD | -7,725,000USD | -4,801,000USD | -8,244,000USD | -17,472,000USD |
| Capital Expenditures | -209,000USD | -189,000USD | -2,000USD | -43,000USD | -19,000USD | -4,000USD | -3,999USD | -3,000USD |
| Free Cash Flow | -88,419,000USD | -58,026,000USD | -10,914,000USD | -18,805,000USD | -7,744,000USD | -4,805,000USD | -8,247,999USD | -17,475,000USD |
| Investments | -96,536,000USD | — | — | — | — | — | — | — |
| Total Cashflows From Investing Activities | -96,745,000USD | -330,127,000USD | -2,000USD | -43,000USD | -19,000USD | -4,000USD | 3,046,000USD | 12,926,000USD |
| Net Borrowings | 0USD | — | — | — | — | — | — | — |
| Total Cash From Financing Activities | 170,315,000USD | 449,539,000USD | — | 23,093,000USD | 48,452,000USD | 6,560,000USD | 3,104,000USD | 5,847,000USD |
| Issuance Of Capital Stock | 671,000USD | — | — | — | — | — | — | — |
| Change In Cash | -14,640,000USD | 24,144,000USD | -10,914,000USD | 4,288,000USD | 40,708,000USD | 1,755,000USD | -2,094,000USD | 1,301,000USD |
| Begin Period Cash Flow | 61,575,000USD | 37,431,000USD | 53,359,000USD | 49,071,000USD | 8,363,000USD | 6,608,000USD | 8,702,000USD | 7,401,000USD |
| End Period Cash Flow | 46,935,000USD | 61,575,000USD | 42,445,000USD | 53,359,000USD | 49,071,000USD | 8,363,000USD | 6,608,000USD | 8,702,000USD |
| Unclassified Operating Cash Flow | -24,240,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 169,644,000USD | — | — | — | — | — | 3,415,000USD | 6,103,000USD |
| Unclassified Investing Cash Flow | — | -329,938,000USD | — | — | — | — | 3,049,999USD | 12,929,000USD |
| Other Cashflows From Financing Activities | — | — | — | — | — | — | -311,000USD | -256,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.